Advanced Biotechnology Projects Roadshow (AM)

Agendas
09:00 - 12:20
  • 主持人 Moderator
  • 于永明, 瀛玑智药（北京）科技有限公司总经理
  • YU Yongming, General Manager, Yingji Zhiyao (Beijing) Technology Co., Ltd.
09:00 - 09:20
  • 项目1
  • Project 1
  • 抗脑胶质瘤PDC药物LB001
  • LB001, a Peptide-Drug Conjugate Targeting Glioma
  • 张金华, 驯鹿生物创始人、董事长兼首席执行官
  • ZHANG Jinhua, Founder, Chairwoman, and CEO of IASO Bio
09:20 - 09:40
  • 项目2
  • Project 2
  • 南京滴力ADC项目介绍
  • Nanjing Diligene Bio ADC Projects
  • 刘军帅, 中国药促会政策专委会副主委
  • LIU Junshuai, Vice-Chairman, PhIRDA Medicinal Policy Specialty Committee
09:40 - 10:00
  • 项目3
  • Project 3
  • 针对IgE-FcεRI通路的阻断性抗体药物开发
  • Development of Blocking Antibody Drugs Targeting the IgE-FcεRI Pathway
  • 贺菊颖, 中信建投证券研究发展部联席负责人、未来产业和政策研究院执行院长
  • HE Juying, Co-Head of Research & Development Department, China Securities Co., Ltd.; Executive Dean of the Institute for Future Industries and Policy
10:00 - 10:20
  • 项目4
  • Project 4
  • 利用tBE技术开发创新型碱基编辑基因疗法
  • Advancing Clinical Applications of Gene Editing Using Innovative Transformer Base Editor (tBE)
  • 徐柏玲, 中国医学科学院药物研究所研究员
  • XU Bailing, Professor, Institute of Materia Medica, Chinese Academy of Medical Sciences
10:20 - 10:40
  • 项目5
  • Project 5
  • 科迈生物：基于生成式AI和多智能体协作的抗体从头设计平台
  • Revolutionizing Antibody De Novo Designing Platform Based on Generative AI And Multi-Agent Collaboration
  • 王校复, 太保健康研究院项目负责人
  • WANG Xiaofu, Head of Health Research Institute Projects, China Pacific Insurance (Group) Co., Ltd.
10:40 - 11:00
  • 项目6
  • Project 6
  • 基于类脑神经网络+AI在高效发现CNS候选药物中的应用和实践
  • Brain-like Neural Networks (BNNs) + AI Enhance CNS Drug Discovery
  • 金祺, 凯泰资本合伙人
  • JIN Qi, Partner, Kaitai Capital
11:00 - 11:20
  • 项目7
  • Project 7
  • 吸入靶向TSLP纳米抗体粉雾剂的研究与开发
  • Development of an Inhaled TSLP-Targeting Nanobody Dry Powder Inhaler
  • 杜向阳, 西南证券研究院副院长，医药生物行业首席分析师
  • DU Xiangyang, Deputy Dean and Chief Healthcare Analyst of Southwest Securities Equity Research Department
11:20 - 11:40
  • 项目8
  • Project 8
  • 新一代IG+抗体平台驱动的药物创新
  • Next-generation IG+ Antibody Platform-driven Drug Innovation
  • 袁清慧, 中信建投证券医药行业首席分析师
  • YUAN Qinghui, Head of Healthcare Research at China Securities
11:40 - 12:00
  • 项目9
  • Project 9
  • 现货型肿瘤原位治疗性疫苗
  • Off-the-Shelf in Situ Therapeutic Vaccine for Tumors
  • 李贵荣, 南京安懋华药业有限公司创始人/董事
  • LI Guirong, Director of Nanjing Amazigh Pharma Ltd.
12:00 - 12:20
  • 项目10
  • Project 10
  • 全球首个临床III期的HSV2溶瘤病毒最新进展
  • The Latest Progress of the World's First Phase III Clinical HSV2 Oncolytic Virus
  • 于海波, 中国医学科学院药物研究所教授
  • YU Haibo, Professor, Institute of Materia Medica, Chinese Academy of Medical Sciences